What is TEAM's health score?

Atlassian Corp (TEAM) has a TradeApes health score of 43 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is TEAM's estimated fair value?

Based on our 5-year discounted cash flow model, Atlassian Corp's estimated fair value is $63.45 per share, representing a -32.0% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is TEAM undervalued or overvalued?

Our model currently rates TEAM as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

2 free score cards remaining

Atlassian Corp (TEAM)

Technology Overvalued low weak

$93.29

Updated: 2026-07-18

TradeApes Score

Financial Strength

30 Weak

Operating Trend

40 Weak

Relative Value

55 Mixed

Capital Allocation

30 Weak

Risk Management

70 Healthy

Est. Fair Value $63.45

DCF Upside -32.0%

Sector Rank #11562 of 15001

Key Findings

+ Free cash flow positive — business generates real spendable cash

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Industry Related Stocks

ACI WORLDWIDE, INC. (ACIW) ADOBE INC. (ADBE) Autodesk, Inc. (ADSK) AUDIOEYE INC (AEYE) C3.ai, Inc. (AI) FIREFLY NEUROSCIENCE, INC. (AIFF)

See all Technology stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.